We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$61.9B
1-Year Est. Return
29.81%
This Fund
S&P 500
This Quarter
Est. Return
+15.18%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
–
AUM
$46.2B
AUM Growth
+$4.02B
(+9.6%)
Cap. Flow
-$2.06B
Cap. Flow
% of AUM
-4.46%
Top 10 Holdings %
Top 10 Hldgs %
19.65%
Holding
934
New
52
Increased
488
Reduced
320
Closed
33
Top Buys
| 1 |
Linde
LIN
|
+$191M |
| 2 |
Microsoft
MSFT
|
+$169M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$162M |
| 4 |
Netflix
NFLX
|
+$126M |
| 5 |
Philip Morris
PM
|
+$87.5M |
Top Sells
| 1 |
Pfizer
PFE
|
+$231M |
| 2 |
Banco Bradesco
BBD
|
+$182M |
| 3 |
Amdocs
DOX
|
+$175M |
| 4 |
Oracle
ORCL
|
+$156M |
| 5 |
Chevron
CVX
|
+$145M |
Sector Composition
| 1 | Financials | 15.39% |
| 2 | Technology | 14.48% |
| 3 | Consumer Discretionary | 13.41% |
| 4 | Healthcare | 10.59% |
| 5 | Communication Services | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Nice
NICE
$5.88B
| $30.2M | 0.07% |
+246,139
| New | +$27.7M |
|
277
Intuitive Surgical
ISRG
$124B
| $30M | 0.07% |
157,683
-16,716
| -10% | -$2.97M |
|
278
Kohl's
KSS
$1.95B
| $29.5M | 0.06% |
429,051
-91,506
| -18% | -$6.21M |
|
279
Univest Financial
UVSP
$1.23B
| $29.4M | 0.06% |
1,200,181
-76,662
| -6% | -$1.87M |
|
280
Becton Dickinson
BDX
$43.4B
| $29.4M | 0.06% |
120,528
+38,563
| +47% | +$9.12M |
|
281
Starwood Property Trust
STWD
$6.26B
| $29.2M | 0.06% |
1,308,266
-3,359
| -0.3% | -$73.3K |
|
282
NetEase
NTES
$84B
| $29.1M | 0.06% |
602,755
+19,600
| +3% | +$932K |
|
283
Chegg
CHGG
$89.8M
| $28.8M | 0.06% |
755,521
+479,926
| +174% | +$17.5M |
|
|
HOLX
284
DELISTED
Hologic
HOLX
| $28.6M | 0.06% |
589,967
-50,620
| -8% | -$2.28M |
|
285
TE Connectivity
TEL
$59.2B
| $28.5M | 0.06% |
352,995
+52,176
| +17% | +$4.21M |
|
286
Charter Communications
CHTR
$16.3B
| $28.5M | 0.06% |
82,133
+25,916
| +46% | +$8.54M |
|
|
HES
287
DELISTED
Hess
HES
| $28.5M | 0.06% |
472,623
-12,639
| -3% | -$695K |
|
288
Rogers Corp
ROG
$2.35B
| $28.3M | 0.06% |
178,203
-47,935
| -21% | -$6.47M |
|
289
Stryker
SYK
$122B
| $27.8M | 0.06% |
140,540
+44,430
| +46% | +$8M |
|
290
Culp Inc
CULP
$46.9M
| $27.8M | 0.06% |
1,443,736
-3,294
| -0.2% | -$61.3K |
|
291
Travelers Companies
TRV
$77.7B
| $27.7M | 0.06% |
202,232
-65,623
| -24% | -$8.4M |
|
292
Fidelity National Information Services
FIS
$21.7B
| $27.6M | 0.06% |
244,163
+12,996
| +6% | +$1.39M |
|
293
Aon
AON
$78.6B
| $27.6M | 0.06% |
161,725
-30,827
| -16% | -$5M |
|
294
Evolent Health
EVH
$657M
| $27.4M | 0.06% |
2,181,251
+75,483
| +4% | +$1.2M |
|
295
Insulet
PODD
$11.4B
| $27.3M | 0.06% |
287,252
+78,230
| +37% | +$6.71M |
|
296
Emergent Biosolutions
EBS
$392M
| $27.3M | 0.06% |
539,983
-247,043
| -31% | -$14.6M |
|
|
TIF
297
DELISTED
Tiffany & Co.
TIF
| $27.1M | 0.06% |
256,728
+128,047
| +100% | +$11.8M |
|
298
Infosys
INFY
$46.3B
| $27M | 0.06% |
2,464,676
-192,433
| -7% | -$2.04M |
|
299
Verisk Analytics
VRSK
$26.3B
| $26.9M | 0.06% |
202,415
+25,579
| +14% | +$3.11M |
|
|
HSKA
300
DELISTED
Heska Corp
HSKA
| $26.9M | 0.06% |
315,599
+62,685
| +25% | +$5.65M |
|
Similar funds
Aberdeen Group's Q1 2019 Portfolio in Review
As of Q1 2019, Aberdeen Group held 934 positions worth $46.2B, up 9.6% from $42.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Aberdeen Group withdrew a net $2.06B in Q1 2019, closing 33 positions and reducing 320 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $36M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Aberdeen Group opened a new position in Linde worth $203M.
- Aberdeen Group's largest Q1 2019 buy was Linde: 1,152,668 shares worth $203M.
- Aberdeen Group added most to Microsoft in Q1 2019, an estimated $169M increase.
- Aberdeen Group's biggest Q1 2019 reduction was Pfizer, cutting an estimated $231M.
- Aberdeen Group fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $36M.
- Aberdeen Group's ten largest holdings make up 20% of its $46.2B portfolio in Q1 2019.
- Aberdeen Group opened 52 new positions and closed 33 in Q1 2019.
- Aberdeen Group's portfolio value rose 9.6% quarter-over-quarter to $46.2B.
Based on Aberdeen Group's 13F filing for Q1 2019, filed 14 May 2019.